Cargando…
β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke
Beta-2 Glycoprotein I (β2-GPI) is the main target of anti-phospholipid antibodies (aPL) in the autoimmune anti-phospholipid syndrome, characterized by increased risk of stroke. We here investigated the antibody independent role of β2-GPI after ischemia/reperfusion, modeled in vivo by transient middl...
Autores principales: | Grossi, Claudia, Artusi, Carolina, Meroni, PierLuigi, Borghi, Maria Orietta, Neglia, Laura, Lonati, Paola Adele, Oggioni, Marco, Tedesco, Francesco, De Simoni, Maria-Grazia, Fumagalli, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323337/ https://www.ncbi.nlm.nih.gov/pubmed/33444093 http://dx.doi.org/10.1177/0271678X20984551 |
Ejemplares similares
-
Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018) -
Specific contribution of mannose-binding lectin murine isoforms to brain ischemia/reperfusion injury
por: Neglia, Laura, et al.
Publicado: (2019) -
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
por: Durigutto, Paolo, et al.
Publicado: (2019) -
Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome
por: Grossi, Claudia, et al.
Publicado: (2023) -
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
por: Lonati, Paola Adele, et al.
Publicado: (2019)